sxRNA-based antiviral therapy (Hocuslocus)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamesxRNA-based antiviral therapy (Hocuslocus)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHocuslocus Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHocuslocus Llc
Active IndicationsN/A
Inactive IndicationsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A